Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

F 13640

Known as: F13640 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Serotonin 1A receptors are known to play an important role in many psychiatric and neurodegenerative disorders. Currently, all… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
2016
2016
Although l-DOPA alleviates the motor symptoms of Parkinson's disease (PD), it elicits troublesome l-DOPA-induced dyskinesia (LID… Expand
2015
2015
L-DOPA is the gold-standard treatment for Parkinson's disease (PD), but induces troublesome dyskinesia after prolonged treatment… Expand
  • table 1
2011
2011
RationaleF13640 (befiradol) is a novel 5-HT1A receptor agonist with exceptional selectivity vs. other receptors and binding sites… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2009
2009
Brain serotonin 5-HT(1A) receptor, a traditional target for the treatment of mood disorders, modulates intracellular signalling… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2005
2005
We studied the effects of the high-efficacy 5-hydroxytryptamine1A (5-HT1A) receptor agonist, F 13640 on both formalin-induced… Expand
2005
2005
F 13640 is a newly discovered high-efficacy 5-HT(1A) receptor agonist that produces exceptional analgesia in animal models of… Expand
2005
2005
Evidence shows that serotonin (5-HT) is involved in the transmission of nociception in the central nervous system. Using a new… Expand
Highly Cited
2003
Highly Cited
2003
Previously, we have reported that in rat models of chronic pain, in particular, the very-high-efficacy 5-HT1A agonist F 13640… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
2002
2002
The effects of acute intraperitoneal injections of the 5-HT(1A) receptor agonists F 13640 [(3-chloro-4-fluoro-phenyl)-[4-fluoro-4… Expand